New Delhi: The union health ministry has notified the Drugs & Cosmetics (Compounding of Offences) Rules 2025 to allow minor offences to be settled by fine or penalties. Mint earlier reported about the Centre framing draft rules for compounding of offences under Drugs & Cosmetics Act. Also Read | Wellness startups board the weight loss…
New Delhi: In a bid to eradicate leprosy by 2027, the health ministry has urged states and Union territories to implement a revised treatment regimen for paucibacillary and multibacillary cases. As per the new plan, the government has introduced a three-drug regimen for paucibacillary cases in place of a two-drug regimen for six months, being…
New Delhi: The Indian Pharmacopoeia Commission (IPC), a body under the health ministry, has named five lifesaving drugs as having shown serious side effects. The drugs are Metronidazole, an antibiotic; Luliconazole, an antifungal; Dalteparin, used for cancer treatment; diabetics drug Gliclazide and Tramadol, a painkiller. During a recently conducted analysis of adverse drug reactions (ADRs),…
New Delhi: The government may make it mandatory for packages containing narcotics to carry a barcode while it mulls building a portal to identify, track and monitor the illegal sale of narcotics. In view to recent cases of abuse of narcotics meant for medicinal use, the government is devising a mechanism to ensure the tracking…
New Delhi: A total of 103 applications have been approved for Central financial assistance to MSME (micro, small and medium enterprises) drug firms wishing to upgrade to international standards, the government said, addressing an impediment to Indiaâs pharma export ambitions. The total financial support under the governmentâs revamped Pharmaceutical Technology Upgradation Assistance Scheme amounted to…
New Delhi: The government body charged with setting quality standards for drugs has launched a review of the safety and efficacy norms for 13 commonly used but âvery oldâ drugs and asked pharmaceutical companies to submit their manufacturing licence approval letters. The Indian Pharmacopoeia Commission (IPC), part of the Drugs Controller General of India, said…
To prevent misuse of raw materials collected from blood centres, the Union health ministry has issued new norms for domestic manufacturers of kits and medical devices requiring Transfusion-Transmissible Infection (TTI) sero reactive blood bags from blood centres as a raw material for preparing in vitro diagnostic (IVD) reagents. As part of the plan, every firm…
Seeking urgent Union government intervention to overcome the lack of affordable access to medicines for treating Spinal Muscular Atrophy (SMA) and the need to allow local manufacturers to make the generic version of the drugs to cut down costs Haris Beeran, Rajya Sabha member has written to the Health Ministry.   In India, SMA is classified…
New Delhi: P. K. Mishra, principal secretary to Prime Minister Narendra Modi, reviewed the Mpox situation in the country after the World Health Organization (WHO) again declared the virus a global public health emergency. Mishra chaired a high-level meeting to review the status of preparedness for Mpox in the country and related public health measures…
Union health ministry said on Saturday there are currently no reported cases of Monkeypox in India even though cautionary measures will be put in place to prevent and control the spread of the disease. Earlier in the day, a review meeting was held to assess the risk of a large outbreak of Monkeypox. Although the…
